A survivor of prostate cancer decided to launch a group for men affected by the disease, after discovering there was a lack of support in ...

A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a ...

Novartis manufacturers Pluvicto which benefits men with advanced prostate cancer, and oncologists have told the HSE that ...

Researchers found that one in three men had minimal symptomatic benefits from tamsulosin, the most commonly prescribed medication for older men with a form of urinary tract infections, and suggest ...

Houston biopharma company CoRegen said it has received US Food and Drug Administration clearance to begin a Phase I/II trial of CRG-150, an adoptive cell therapy targeting steroid receptor coactivator ...

Phase 1/2a Clinical Trial to Evaluate Safety and Preliminary Efficacy of CRG-150 in Metastatic Triple-Negative Breast Cancer, HR+ HER2− Breast Cancer, and Prostate Cancer at Leading Academic Medical C ...

Hope for men with high-risk non-metastatic hormone resistant prostate cancerBy Dr Jacqueline Schmitt - Manager, Research ...

The FDA's approval of vepdegestrant marks a groundbreaking shift in cancer therapy by introducing PROTAC technology for advanced breast cancer treatment.

The treatment, called Pasritamig, teaches the immune system's T cells to target and attack cancer cells in the prostate.

The U.S. Food and Drug Administration (FDA) has approved a new therapy regimen for patients with "double-positive" metastatic ...

Scientists are asking an unusual question: what if one type of prostate cancer should no longer be called cancer? A new ...

Men diagnosed with metastatic prostate cancer that lacks the PTEN protein now have a targeted drug option for the first time.